The research on this molecule spans decades and hundreds of studies
In human growth-hormone-deficiency trials using recombinant native IGF-1 (mecasermin, brand name Increlex), the approved dose range is 0.04-0.12 mg/kg twice daily by subcutaneous injection, titrated to IGF-1 levels in the age- and sex-normalised reference range [15]
This is a preview of subscription content, access via your institution Access options Access Nature and 54 other Nature Portfolio journals Get Nature+, our best-value online-access subscription 27,99 / 30 days cancel any time Subscribe to this journal Receive 12 print issues and online access 176,64 per year only 14,72 per issue Buy this article Purchase on SpringerLink Instant access to the full article PDF
Both are researched in tendon, ligament, and soft-tissue models, but through different biological mechanisms
Phipps Pharmacy, a compounder based in Tennessee, posted videos on Instagram and TikTok earlier this year announcing the availability of sublingual semaglutide drops
N Engl J Med 2024;391:109-21.ArticlePubMed 77